Comparison of the Effect of Omeprazole,Pantoprazole,Esomeprazole and Lansoprazole on the Patients with Gastroesophageal Reflux Disease

Phase 4

• Conditions: Gastro-oesophageal Reflux Disease.; Gastro-esophageal reflux disease

• Registration Number: IRCT20171007036616N1
• Lead Sponsor: Abidi Pharma

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Patients with Gastroesophageal Reflux Disease with frequent symptoms(2 or more symptoms per week)

Exclusion Criteria

Weight Loss
History of cancer
Odinophagia
Dysphagia

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Heart Burn. Timepoint: 0 , 2 , 4 , 8 weeks. Method of measurement: questionnaire.;Acid Regurgitation. Timepoint: 0 , 2 , 4 , 8 weeks. Method of measurement: questionnaire.

Secondary Outcome Measures

Name	Time	Method
Total Satisfaction. Timepoint: 0,2,4,8 week. Method of measurement: Questionnaire.